Home›Companies›Biotech & Pharma›Omnipulse Biosciences

Omnipulse Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 2, 2024·Suggest an edit

About Omnipulse Biosciences

Omnipulse Biosciences is a private company based in Cambridge, Massachusetts, incorporated in 2022 in Delaware. It has reported $6,999,999 raised in one offering on Form D since January 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 15, 2023Jan 2, 2024$6,999,999of $12.5M target2$3.4MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Omnipulse Biosciences's Form D filed Jan 2, 2024.

AJ
Ana Jacklenec
Director and promoter
DZ
David Zhu
Director
RF
Robert Farra
President and director
JD
FH
Felicia Hsu
Director
RL
Robert Langer
Director and promoter

Sources

  1. SECOmnipulse Biosciences, Inc. filing history